Avtor/Urednik | Bogovič, Meta; Kobal, Nataša | |
Naslov | Klinična farmacija, farmakoepidemiologija in farmakoekonomika novih kardiovaskularnih zdravil | |
Prevedeni naslov | Clinical pharmacy, pharmacoepidemiology and pharmacoeconomics of the new cardiovascular drugs | |
Tip | članek | |
Vir | Farm Vestn | |
Vol. in št. | Letnik 50, št. Spec Issue | |
Leto izdaje | 1999 | |
Obseg | str. 149-57 | |
Jezik | slo | |
Abstrakt | Drugs for treatment of cardiovascular diseases are important segment in clinical, pharmacoeconomical and pharmacoepi-demiological evaluations of drugs considering frequency of cardiovascular diseases and consequence mortality. Consumption (use) of the drugs is followed on the first and second level of health system. Pharmacodinamic and pharmacokinetic parameters of some new drugs for treatment of cardiovascular diseases and their significance in therapy decision are reviewed in this article. | |
Izvleček | Glede na pogostnost bolezni srca in ožilja in posledično njihovo smrtnost, je skupina zdravil, ki se uporabljajo za zdravljenje, pomemben segment za proučevanje iz kliničnega, farmakoekonomskega in farmakoepidemiološke ga vdika. Porabo teh zdravil spremljamo tako na ravni primarnega kakor tudi sekundarnega zdravstva. Članek predstavlja farmakodinamske in farmakokinetične parametre za nekatera novejša zdravila za zdravljenje bolezni srca in ožilja. Prikazana je njihova pomembnost v izbiri zdravljenja. | |
Deskriptorji | CARDIOVASCULAR DISEASES PHARMACOEPIDEMIOLOGY DRUG UTILIZATION DRUG COSTS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ANGIOTENSIN II CALCIUM CHANNEL BLOCKERS VASODILATOR AGENTS ANTIHYPERTENSIVE AGENTS ANTILIPEMIC AGENTS |